Rentschler Biopharma SE, headquartered in Laupheim, Germany, is a leading, family-owned, full-service biopharma CDMO. Owing to agile decision making and efficient...
14.02.2020
- US contract development and manufacturing organization Catalent has acquired MaSTherCell Global for $315 million cash, boosting its cell and gene therapy capabilities. The New...
11.02.2020
- Bayer is collaborating with Meiogenix to accelerate the development of the French biotech’s proprietary technologies for plant breeding and genome editing applications. The German...
04.02.2020
- German pharmaceuticals, chemicals and life sciences group Merck KGaA is investing €250 million over three years in a new facility at Corsier-sur-Vevey, Switzerland, which will be...
28.01.2020
- Lonza’s search for a new CEO is under way but the Swiss-based fine chemicals producer and CDMO’s supervisory board has warned that finding the right leader could take longer than...
27.01.2020
- Sanofi has completed its acquisition of US biotech Synthorx as planned for $68 per share in cash. This follows expiration of the French pharma giant’s tender offer for all of the...
24.01.2020
- US drugmaker Eli Lilly is planning to invest $474 million in a new plant in North Carolina’s Research Triangle Park (RTP) that will produce injectable medicines such as insulin, as...
22.01.2020
- Shanghai, China-based Wuxi Biologics has taken a long lease on one of Bayer’s finished drug plants at Leverkusen, Germany, and will buy the plant’s equipment. The facility’s 24...
10.01.2020
- Almirall, a dermatology-focused drugmaker based in Barcelona, Spain, has taken an option to acquire US biotech Bioniz Therapeutics as part of a deal that would give it full global...
19.12.2019
- Danish biotech Novozymes and US-based Green Plains have formed an exclusive partnership to commercialize biological solutions for producing high-protein ingredients for aquaculture...
